| Current Price | $49.37 | Mkt Cap | $3.0B |
|---|---|---|---|
| Open | $49.81 | P/E Ratio | -5.35 |
| Prev. Close | $49.37 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $48.94 - $50.33 | Volume | 489,742 |
| 52-Wk Range | $37.82 - $68.63 | Avg. Daily Vol. | 633,493 |
| Current Price | $49.37 | Mkt Cap | $3.0B |
|---|---|---|---|
| Open | $49.81 | P/E Ratio | -5.35 |
| Prev. Close | $49.37 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $48.94 - $50.33 | Volume | 489,742 |
| 52-Wk Range | $37.82 - $68.63 | Avg. Daily Vol. | 633,493 |
The best Bull and Bear pitches based on recency and number of recommendations.
The company faces stiff competition from LOXO in developing RET targeting cancer treatment and LOXO has the pole position at ASCO over the coming days because of an oral presentation it's making. That could weigh down BPMC shares in the short-term,… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about BPMC.
Recs
freecapital
(75.99)
Submitted: 4/23/2019 5:03:06 AM :
Start Price:
$75.72
NASDAQ:BPMC Score:
-83.21
fuma
Recs
TMFEBCapital
(72.70)
Submitted: 6/1/2018 10:50:57 AM :
Start Price:
$83.99
NASDAQ:BPMC Score:
-99.05
The company faces stiff competition from LOXO in developing RET targeting cancer treatment and LOXO has the pole position at ASCO over the coming days because of an oral presentation it's making. That could weigh down BPMC shares in the short-term, but this company's RET data is also compelling. Additionally, its CEO is the former President of Algeta -- a company that developed Xofigo and was sold to Bayer. With proven management and a good shot at a game-changing approach to medicine, I think this one will be a one-time winner, despite the risk of a short-term drop.
Find the members with the highest scoring picks in BPMC.
t0bes (23.36) Score: +202.70
The Score Leader is the player with the highest score across all their picks in BPMC.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| SwampFox18 | 37.74 | 7/29/2022 |
|
5Y | $50.69 | -2.60% | +5.24% | -7.84 | 0 Comment | |
| km00nster | < 20 | 6/26/2015 |
|
5Y | $27.96 | +76.57% | +105.14% | -28.57 | 0 Comment | |
| gunterle | 70.42 | 1/24/2017 |
|
5Y | $32.28 | +52.94% | +89.40% | -36.45 | 0 Comment | |
| jettyjett | 54.35 | 5/30/2017 |
|
5Y | $35.50 | +39.07% | +78.56% | -39.49 | 0 Comment | |
| PandaTears | < 20 | 7/26/2021 |
|
5Y | $85.15 | -42.02% | -1.80% | -40.22 | 0 Comment | |
| TMFfuma102 | 84.69 | 4/14/2021 |
|
5Y | $93.12 | -46.98% | +4.50% | -51.48 | 0 Comment | |
|
efarev | 30.84 | 5/23/2017 |
|
5Y | $39.00 | +26.59% | +79.78% | -53.19 | 0 Comment |
| user400 | < 20 | 2/25/2020 |
|
5Y | $65.22 | -24.30% | +33.50% | -57.80 | 0 Comment | |
| stainsolution | < 20 | 3/8/2021 |
|
5Y | $94.35 | -47.67% | +12.15% | -59.82 | 0 Comment | |
| iRowboat | < 20 | 3/24/2021 |
|
1Y | $98.45 | -49.85% | +10.31% | -60.16 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
